Global Antimicrobial Resistance Research and Development Hub
- 13 Sep 2019
- 2 min read
Recently, India has joined the Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub as a new member.
- Working with AMR(R&D) Hub would help India to expand existing capabilities, resources and collectively focus on new R&D intervention to address drug-resistant infections present in the country.
- Global Antimicrobial Resistance (AMR) Research and Development (R&D) Hub is a collaboration of 16 countries, the European Commission, two philanthropic foundations and four international organizations (as observers).
- It was launched in 2018 during the 71st session of the World Health Assembly, following a call from G20 Leaders in 2017.
- It is supported through a Secretariat, established in Berlin, Germany.
- It aims to further improve the coordination of international efforts and initiatives to tackle Antimicrobial Resistance while further increasing investments into R&D for AMR.
- The work of the Global AMR R&D Hub will be aligned to the priorities set by
- It enforces the One Health Approach by including environmental aspects and veterinary medicine against antimicrobial resistance.
- It integrates human and animal health, worldwide food safety and environmental factors.